{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:58Z","timestamp":1792686478701,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.autrev.2020.102670","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T22:31:13Z","timestamp":1600122673000},"page":"102670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle"],"prefix":"10.1016","volume":"19","author":[{"given":"Guillermo","family":"Carvajal Alegria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boukhlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0005","first-page":"137","article-title":"Rhizomelic pseudopolyarthritis","volume":"6","author":"Forestier","year":"1954","journal-title":"Reumatismo"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.16.2.230","article-title":"Myalgic syndrome with constitutional effects; polymyalgia rheumatica","volume":"16","author":"Barber","year":"1957","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/ard.25.3.203","article-title":"Polymyalgia rheumatica and temporal arteritis","volume":"25","author":"Dixon","year":"1966","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.28.3.267","article-title":"Temporal arteriography. A new technique for the investigation of giant cell arteritis and polymyalgia rheumatica","volume":"28","author":"Gillanders","year":"1969","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.autrev.2020.102670_bb0025","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA."},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.autrev.2016.02.016","article-title":"Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117 patients","volume":"15","author":"Espitia","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2018.10.001","article-title":"The association of other autoimmune diseases in patients with Graves\u2019 disease (with or without ophthalmopathy): review of the literature and report of a large series","volume":"18","author":"Ferrari","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1568-9972(03)00064-8","article-title":"Immunopathways in giant cell arteritis and polymyalgia rheumatica","volume":"3","author":"Weyand","year":"2004","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0055","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","article-title":"Recent advances in our understanding of giant cell arteritis pathogenesis","volume":"16","author":"Samson","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000694","article-title":"Polymyalgia rheumatica: an autoinflammatory disorder?","volume":"4","author":"Floris","year":"2018","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","article-title":"Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?","volume":"55","author":"van der Veen","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0075","first-page":"624","article-title":"Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study","volume":"23","author":"Ferraccioli","year":"1996","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/annrheumdis-2015-208742","article-title":"Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study","volume":"75","author":"Devauchelle-Pensec","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jbspin.2016.07.003","article-title":"Has the time come for biotherapies in giant cell arteritis and polymyalgia rheumatica?","volume":"83","author":"Devauchelle-Pensec","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/rheumatology\/kex477","article-title":"Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable","volume":"57","author":"Devauchelle-Pensec","year":"2018","journal-title":"Rheumatology."},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0095","first-page":"529","article-title":"Immunogenetics of polymyalgia rheumatica","volume":"11","author":"al-Jarallah","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.1780370411","article-title":"HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis","volume":"37","author":"Weyand","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0105","first-page":"671","article-title":"Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in polymyalgia Rheumatica","volume":"24","author":"Guerne","year":"1997","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0110","first-page":"94","article-title":"Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population","volume":"25","author":"Combe","year":"1998","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0115","first-page":"122","article-title":"Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association","volume":"28","author":"Gonzalez-Gay","year":"2001","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0248-8663(96)80789-2","article-title":"HLA DRB1 polymorphism in rhizomelic pseudo-polyarthritis and Horton disease","volume":"16","author":"Labbe","year":"1995","journal-title":"Rev Med Interne"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/rheumatology\/35.7.632","article-title":"Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404","volume":"35","author":"Haworth","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2370.2001.00228.x","article-title":"DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France","volume":"28","author":"Reviron","year":"2001","journal-title":"Eur J Immunogene Off J Br Soc Histocompat Immunogenetics"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.58.5.303","article-title":"HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity","volume":"58","author":"Salvarani","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0140","first-page":"745","article-title":"A genetic approach to the aetiology of giant cell arteritis: depletion of the CD8+ T-lymphocyte subset in relatives of patients with polymyalgia rheumatica and arteritis temporalis","volume":"13","author":"Johansen","year":"1995","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0145","first-page":"2140","article-title":"Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association","volume":"25","author":"Dababneh","year":"1998","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.semarthrit.2003.12.001","article-title":"HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis","volume":"34","author":"Mart\u00ednez-Taboda","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0155","first-page":"726","article-title":"T-786C single nucleotide polymorphism of the endothelial nitric oxide synthase gene as a risk factor for endothelial dysfunction in polymyalgia rheumatica","volume":"33","author":"L\u00f6ffers","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0160","first-page":"1215","article-title":"Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica\/giant cell arteritis: association with disease risk and severity","volume":"27","author":"Salvarani","year":"2000","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0165","first-page":"502","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica","volume":"29","author":"Amoli","year":"2002","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0170","first-page":"391","article-title":"RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis","volume":"18","author":"Makki","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0175","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0180","first-page":"675","article-title":"Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica","volume":"18","author":"Boiardi","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humimm.2008.10.011","article-title":"Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN*2\/2 genotype with polymyalgia rheumatica","volume":"70","author":"Alvarez-Rodriguez","year":"2009","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0190","first-page":"591","article-title":"Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica","volume":"18","author":"Salvarani","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0195","first-page":"179","article-title":"IL-6 promoter polymorphism at position \u2212174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis","volume":"20","author":"Gonzalez-Gay","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0200","first-page":"703","article-title":"Relationship between interleukin 6 promoter polymorphism at position \u2212174, IL-6 serum levels, and the risk of relapse\/recurrence in polymyalgia rheumatica","volume":"33","author":"Boiardi","year":"2006","journal-title":"J Rheumatol"},{"issue":"6 Suppl 36","key":"10.1016\/j.autrev.2020.102670_bb0205","first-page":"S18","article-title":"Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica","volume":"22","author":"Gonzalez-Gay","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/ard.35.2.158","article-title":"Circulating immunoblasts in polymyalgia rheumatica","volume":"35","author":"Eghtedari","year":"1976","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2020.102670_bb0215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.1780230909","article-title":"Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica","volume":"23","author":"Papaioannou","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.40.4.360","article-title":"Circulating immune complexes in polymyalgia rheumatica and giant cell arteritis","volume":"40","author":"Park","year":"1981","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2020.102670_bb0225","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.1780261209","article-title":"Decrease of the OKT8 positive T cell subset in polymyalgia rheumatica. Lack of correlation with disease activity","volume":"26","author":"Benlahrache","year":"1983","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0230","first-page":"333","article-title":"Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumatica","volume":"2","author":"Chelazzi","year":"1984","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0235","first-page":"306","article-title":"Decreased level of suppressor\/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity","volume":"12","author":"Elling","year":"1985","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0240","first-page":"627","article-title":"CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset","volume":"7","author":"Elling","year":"1989","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/ard.48.4.307","article-title":"Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis","volume":"48","author":"Dasgupta","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0250","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/rheumatology\/32.8.666","article-title":"Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica\/giant cell arteritis","volume":"32","author":"Macchioni","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0255","first-page":"629","article-title":"The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica\/giant cell arteritis","volume":"11","author":"Arnold","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0260","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.53.11.780","article-title":"The Cambridge dilemma","volume":"53","author":"Elling","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0265","first-page":"1020","article-title":"The value of percentage of CD8+ T lymphocyte levels in distinguishing polymyalgia rheumatica from early rheumatoid arthritis","volume":"22","author":"Corrigall","year":"1995","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0270","first-page":"155","article-title":"A reduced CD8+ lymphocyte subset distinguishes patients with polymyalgia rheumatica and temporal arteritis from patients with other diseases","volume":"16","author":"Elling","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0275","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/ard.54.8.640","article-title":"Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis","volume":"54","author":"Salvarani","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0280","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.52.10.730","article-title":"Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment","volume":"52","author":"Pountain","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02208086","article-title":"Peripheral blood lymphocyte subsets in polymyalgia rheumatica","volume":"14","author":"Uddhammar","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0290","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/rheumatology\/35.7.642","article-title":"CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy","volume":"35","author":"Boiardi","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0295","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/sarh.2001.9734","article-title":"Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review","volume":"30","author":"Martinez-Taboada","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0300","first-page":"1865","article-title":"Serum soluble CD4 and CD8 levels in polymyalgia rheumatica","volume":"21","author":"Salvarani","year":"1994","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/clin.1996.0078","article-title":"Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis","volume":"79","author":"Martinez-Taboada","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0310","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/ard.2003.005900","article-title":"Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis","volume":"63","author":"Lopez-Hoyos","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0315","first-page":"303","article-title":"Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations, their soluble receptors and soluble receptor of interleukin-2","volume":"158","author":"Coaccioli","year":"2007","journal-title":"Clin Ter"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0320","first-page":"1079","article-title":"Analysis of peripheral blood lymphocytes using flow cytometry in polymyalgia rheumatica, RS3PE and early rheumatoid arthritis","volume":"26","author":"Shimojima","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0325","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00296-009-0949-9","article-title":"Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica","volume":"30","author":"Dejaco","year":"2010","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0330","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/art.34647","article-title":"Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0335","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211622","article-title":"Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis","volume":"77","author":"Samson","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.semarthrit.2018.04.004","article-title":"Ustekinumab for refractory giant cell arteritis: a prospective 52-week trial","volume":"48","author":"Conway","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0345","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1136\/annrheumdis-2012-201660","article-title":"NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica","volume":"72","author":"Dejaco","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0350","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"van der Geest","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0355","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/rheumatology\/keu526","article-title":"Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica","volume":"54","author":"van der Geest","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0360","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/rheumatology\/kex169","article-title":"Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica","volume":"56","author":"Carvajal Alegria","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0365","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/ard.43.2.264","article-title":"Polymyalgia rheumatica and antimitochondrial antibodies","volume":"43","author":"Sattar","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0370","first-page":"429","article-title":"Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and\/or polymyalgia rheumatica","volume":"143","author":"Berthelot","year":"1992","journal-title":"Ann Med Interne (Paris)"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0375","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0002-9343(92)90803-J","article-title":"Anticardiolipin antibodies in northern Italian population with PMR\/GCA","volume":"92","author":"Salvarani","year":"1992","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0380","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08916939508993340","article-title":"The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell arteritis and\/or polymyalgia rheumatica","volume":"20","author":"Le Tonqu\u00e8ze","year":"1995","journal-title":"Autoimmunity."},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02214942","article-title":"Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes","volume":"14","author":"McLean","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102670_bb0390","first-page":"1694","article-title":"A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis","volume":"22","author":"Chakravarty","year":"1995","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0395","first-page":"241","article-title":"Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis","volume":"63","author":"Meyer","year":"1996","journal-title":"Rev Rhum Engl Ed"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0400","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2249.2002.01751.x","article-title":"Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica","volume":"127","author":"Schmits","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0405","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/annrheumdis-2011-200413","article-title":"Association of ferritin autoantibodies with giant cell arteritis\/polymyalgia rheumatica","volume":"71","author":"Baerlecken","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102670_bb0410","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4757-9182-2_61","article-title":"Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica","volume":"336","author":"Cats","year":"1993","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0415","first-page":"309","article-title":"Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica","volume":"11","author":"Cimmino","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0420","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/ard.53.2.150","article-title":"Antibodies to intermediate filaments in polymyalgia rheumatica\/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response?","volume":"53","author":"Monteagudo","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0425","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P","article-title":"Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l\u2019Art\u00e9rite \u00e0 Cellules G\u00e9antes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2020.102670_bb0430","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0435","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/03009749509095150","article-title":"Clinical value of measuring soluble interleukin-2 receptor in polymyalgia rheumatica","volume":"24","author":"Gripenberg","year":"1995","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0440","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/37.7.797","article-title":"Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis","volume":"37","author":"Pountain","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0445","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/37.7.766","article-title":"Cytokines and adhesion molecules in patients with polymyalgia rheumatica","volume":"37","author":"Uddhammar","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0450","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.55.6.403-b","article-title":"Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis","volume":"55","author":"Caplanne","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0455","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2006.051979","article-title":"Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"65","author":"Cutolo","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102670_bb0460","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.23924","article-title":"Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse\/recurrence risk","volume":"59","author":"Pulsatelli","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0465","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-016-1072-4","article-title":"Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study","volume":"18","author":"Galbo","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0470","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.2008.103663","article-title":"Circulating cytokines in active polymyalgia rheumatica","volume":"69","author":"Alvarez-Rodr\u00edguez","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0475","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/ard.42.3.311","article-title":"Polymyalgia rheumatica: an arthroscopic study of the shoulder joint","volume":"42","author":"Douglas","year":"1983","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0480","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2169\/internalmedicine.32.484","article-title":"Increased RAHA titer and interleukin-6 levels in the synovial fluid in a patient with polymyalgia rheumatica","volume":"32","author":"Zen-nyoji","year":"1993","journal-title":"Intern Med Tokyo Jpn"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0485","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.autrev.2020.102670_bb0490","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1002\/art.27728","article-title":"Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica","volume":"62","author":"Kreiner","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0495","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.pain.2011.01.032","article-title":"Elevated muscle interstitial levels of pain-inducing substances in symptomatic muscles in patients with polymyalgia rheumatica","volume":"152","author":"Kreiner","year":"2011","journal-title":"Pain."},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-510X(94)00214-9","article-title":"Immunofluorescence study of immune complexes in polymyalgia rheumatica","volume":"128","author":"Shintani","year":"1995","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0505","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0303-8467(01)00163-9","article-title":"Polymyalgia rheumatica (PMR): clinical, laboratory, and immunofluorescence studies in 13 patients","volume":"104","author":"Shintani","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0510","first-page":"594","article-title":"Prevalence of synovitis in patients with polymyalgia rheumatica and\/or giant cell arteritis","volume":"64","author":"Devauchelle","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0515","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s002960050039","article-title":"Elderly onset rheumatoid arthritis and polymyalgia rheumatica: ultrasonographic study of the glenohumeral joints","volume":"17","author":"Lange","year":"1998","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0520","first-page":"123","article-title":"Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients","volume":"29","author":"Frediani","year":"2002","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0525","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/art.1780390719","article-title":"Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment","volume":"39","author":"Meliconi","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0530","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-2249.1997.d01-946.x","article-title":"Synovial expression of cell adhesion molecules in polymyalgia rheumatica","volume":"107","author":"Meliconi","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0535","first-page":"562","article-title":"Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica","volume":"24","author":"Pulsatelli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0540","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard.59.10.775","article-title":"Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica","volume":"59","author":"Ellingsen","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0545","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1038\/s41598-017-06826-4","article-title":"Involvement of monocyte subsets in the immunopathology of giant cell arteritis","volume":"7","author":"van Sleen","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0550","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/1529-0131(200011)43:11<2472::AID-ANR14>3.0.CO;2-B","article-title":"Vascular endothelial growth factor production in polymyalgia rheumatica","volume":"43","author":"Meliconi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0555","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0560","doi-asserted-by":"crossref","first-page":"E970","DOI":"10.1073\/pnas.1616848114","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"10.1016\/j.autrev.2020.102670_bb0565","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/CIRCULATIONAHA.117.030423","article-title":"Inhibition of JAK-STAT signaling suppresses pathogenic immune responses in medium and large vessel vasculitis","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation."},{"issue":"14","key":"10.1016\/j.autrev.2020.102670_bb0570","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2019.01.049","article-title":"CD28 signaling controls metabolic fitness of pathogenic T cells in medium and large vessel vasculitis","volume":"73","author":"Zhang","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000426","article-title":"Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study","volume":"3","author":"Cutolo","year":"2017","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0580","first-page":"1293","article-title":"Low serum levels of DHEAS in untreated polymyalgia rheumatica\/giant cell arteritis","volume":"33","author":"Narv\u00e1ez","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102670_bb0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1196\/annals.1351.029","article-title":"Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis","volume":"1069","author":"Sulli","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.autrev.2020.102670_bb0590","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/rheumatology\/keg293","article-title":"Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy","volume":"42","author":"Martinez-Taboada","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2020.102670_bb0595","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0600","first-page":"112","article-title":"Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of mycoplasma pneumoniae infection","volume":"23","author":"Elling","year":"1996","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102670_bb0605","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/ard.49.7.521","article-title":"A seasonal pattern in the onset of polymyalgia rheumatica","volume":"49","author":"Cimmino","year":"1990","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2020.102670_bb0610","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/ard.2005.038901","article-title":"Seasonal pattern in the onset of polymyalgia rheumatica","volume":"64","author":"Perfetto","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102670_bb0615","first-page":"361","article-title":"Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l\u2019Art\u00e9rite \u00e0 cellules G\u00e9antes","volume":"26","author":"Duhaut","year":"1999","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102670_bb0620","first-page":"2624","article-title":"Polymyalgia rheumatica is not seasonal in pattern and is unrelated to parvovirus b19 infection","volume":"30","author":"Peris","year":"2003","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0625","first-page":"953","article-title":"Lack of association between infection and onset of polymyalgia rheumatica","volume":"27","author":"Narv\u00e1ez","year":"2000","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0630","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/rheumatology\/41.4.445","article-title":"No evidence of parvovirus B19, chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis","volume":"41","author":"Helweg-Larsen","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0635","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/ard.58.10.657","article-title":"There is no association between polymyalgia rheumatica and acute parvovirus B19 infection","volume":"58","author":"Hemauer","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2020.102670_bb0640","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/ard.2010.140194","article-title":"Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis","volume":"70","author":"\u00c1lvarez Rodr\u00edguez","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0645","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1189\/jlb.0113034","article-title":"Phagocyte dysfunction in polymyalgia rheumatica and other age-related, chronic, inflammatory conditions","volume":"94","author":"\u00c1lvarez-Rodr\u00edguez","year":"2013","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0650","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000162","article-title":"Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases","volume":"1","author":"Izumi","year":"2015","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.autrev.2020.102670_bb0655","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.39740","article-title":"Brief report: a prospective open-label phase IIa trial of tocilizumab in the treatment of polymyalgia rheumatica","volume":"68","author":"Lally","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"10.1016\/j.autrev.2020.102670_bb0660","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3899\/jrheum.150599","article-title":"Rapid and sustained response to tocilizumab in patients with polymyalgia rheumatica resistant or intolerant to glucocorticoids: a Multicenter open-label study","volume":"43","author":"Toussirot","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102670_bb0665","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2018.00752","article-title":"Impact of aging on the frequency, phenotype, and function of CD161-expressing T cells","volume":"9","author":"van der Geest","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102670_bb0670","first-page":"795","article-title":"Toll-like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"29","author":"Alvarez-Rodriguez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102670_bb0675","first-page":"321","article-title":"Analysis of the rs20541 (R130Q) polymorphism in the IL-13 gene in patients with elderly-associated chronic inflammatory diseases","volume":"8","author":"Alvarez-Rodr\u00edguez","year":"2012","journal-title":"Reumatol Clin"},{"issue":"4","key":"10.1016\/j.autrev.2020.102670_bb0680","first-page":"484","article-title":"Influence of interleukin 10 promoter polymorphisms in polymyalgia rheumatica: disease susceptibility and functional consequences","volume":"32","author":"Alvarez-Rodriguez","year":"2014","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:18:11Z","timestamp":1761599891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":136,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1568997220302457"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102670","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102670"}}